---
layout: post
title: "国药现代：注射用头孢曲松钠获得境外上市许可"
date: 2022-01-28 15:45:19 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600420" data-code="600420|1|1" data-code2="600420|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600420&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600420_0" data-code="K 600420|1|1" data-code2="K 600420|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>国药现代(600420)1月28日晚间公告，公司控股孙公司DALI Pharma收到德国联邦药品和医疗器械机构(BfArM)核准签发的注射用头孢曲松钠(250mg、500mg和1g)的上市许可。</p><p class="em_media">（文章来源：证券时报）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201282265855491>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)